BBY
53
-3
LMT
25
-4
BAC
51
-5
L
43
-4
EIX
37
-11
MPC
36
-2
CF
56
2
PSA
38
-3
BLK
40
-6
MS
62
-7
O
28
8
MTB
41
-3
STZ
18
-12
WBA
69
26
FIS
50
-3
PEP
29
-3
FE
38
-6
ICE
42
-4
MLM
29
-3
FSLR
52
-3
BBY
53
-3
LMT
25
-4
BAC
51
-5
L
43
-4
EIX
37
-11
MPC
36
-2
CF
56
2
PSA
38
-3
BLK
40
-6
MS
62
-7
O
28
8
MTB
41
-3
STZ
18
-12
WBA
69
26
FIS
50
-3
PEP
29
-3
FE
38
-6
ICE
42
-4
MLM
29
-3
FSLR
52
-3
Financhill
Back

CyberArk Software Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Buy
67

CYBR
CyberArk Software

Last Price:
$343.91
Seasonality Move:
13.42%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-6.74%
Buy
67
CyberArk Software (CYBR) is a Buy

Is CyberArk Software a Buy, Sell or Hold?

  • The current CyberArk Software [CYBR] share price is $343.79. The Score for CYBR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • CYBR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CYBR Stock Price Chart

What is CyberArk Software's stock price today?

  • The CyberArk Software share price today is $343.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYBR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $40.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.

CYBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.14 Buy
Relative Strength Index (14 RSI): 65.77 Buy
Chaikin Money Flow: 367666 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (314.48 - 336.44) Buy
Bollinger Bands (100): (276.22 - 319.94) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.44 Sell
Relative Strength Index (14 RSI): 22.69 Sell
Chaikin Money Flow: -2576687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.5 - 57.26) Sell
Bollinger Bands (100): (51.08 - 57.64) Sell

CYBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 338.26 Buy
20-day SMA: 326.19 Buy
50-day SMA: 314.29 Buy
200-day SMA: 275.22 Buy
8-day EMA: 338.56 Buy
20-day EMA: 329.79 Buy
50-day EMA: 316.83 Buy
200-day EMA: 278.72 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.44 Sell
20-day SMA: 52.35 Sell
50-day SMA: 55.3 Sell
200-day SMA: 51.01 Sell
8-day EMA: 48.54 Sell
20-day EMA: 51.52 Sell
50-day EMA: 53.69 Sell
200-day EMA: 49.87 Sell

CyberArk Software Earnings Growth & CYBR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $1.06 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

CyberArk Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):